Abstract
A clinicopathological study was performed on 115 patients (56 males, 59 females; median age 48 yr) with chronic myeloid leukaemia (CML) to reveal initial clinical, but particularly histomorphological features of predictive value for survival. All patients had a trephine biopsy of the bone marrow and entered this study without prior selection. Overall survival was 36 ± 27 months. In addition to multiple interactions between various disease features, multivariate regression analysis showed that of the clinical parameters age, liver size and level of LDH were primarily and most closely associated with prognosis. Of the histomorphological variables, megakaryocytes > 60 mm−2 bone marrow area and fibrosis displayed an unfavourable impact on survival on univariate calculation. On multivariate analysis, however, only pseudo-Gaucher cells remained significant, i.e. exerted an independent and favourable influence on prognosis. Histological features of predictive value were reviewed together with the different categories of a histopathological classification proposed for chronic myeloproliferative diseases by Georgii and co-workers.13
Similar content being viewed by others
References
Jacquillat C, Chastang C, Tanzeret al.: Facteurs de prognostic de la leucemie myeloide chronique. A propos de 798 observations.Nouv Revue fr Hémat 15, 229 (1975).
Hossfeld D K: Chronic myelocytic leukemia: cytogenetic finclings and their relations to pathogenesis and clinic.Semin Hemat 8, 53 (1975).
Schilling R F, Crowley J J: Prognostic signs in chronic myelocytic leukemia.Am J Hemat 7, 1 (1979).
Tura S, Baccarani M, Corbelli G: Staging of chronic myeloid leukaemia.Br J Haemal 47, 105 (1981).
Gomez G A, Sokal J E, Walsh D: Prognostic features at diagnosis of chronic myclocytic leukemia.Cancer 47, 470 (1981).
Cervantes F, Rozman C: A multivariate analysis of prognostic factors in chronic myeloid leukemia.Blood 60, 1298 (1982).
Dacie J, Galton DAG, Bagshaw K Det al: Randomized trial of splenectomy in Ph-1-positive chronic granulocytic leukaemia, inclucling an analysis of prognostic features.Br J Haemal 54, 415 (1983).
Sokal J E, Cox E B, Baccarani, Met al.: Prognostic discrimination in “good-risk” chronic granulocytic leukemia.Blood 63, 789 (1984).
Gralnick H R, Harbor J, Vogel C: Myelofibrosis in chronic granulocytic leukemia.Blood 37, 152 (1971).
Devred C, Diebold J: La myelofibrose au cours des hemopathies. Valeur diagnostique et prognostique. A propos de 402 observations.Sem Hôp Paris 50, 1625 (1974).
Clough V, Geary C G, Hashmi K, Davson J, Knowlson T: Myelofibrosis in chronic granulocytic leukaemia.Br J Haemat 42, 515 (1979).
Lazzarino M, Morra E, Castello A, Inverardi D, Coci A, Pagnucco G, Magrini U, Zei G, Bernasconi C: Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance.Br J Haemat 64, 227 (1986).
Georgii A, Vykoupil K F, Thiele J: Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic finclings and clinical course.Biblthca haemat 50, 41 (1984).
Frisch B, Bartl R, Burkhardt R, Jäger K, Mahl G, Kettner G: Classification of myeloproliferative disorders by bone marrow histology.Biblthca haemat 50, 57 (1984).
Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M: Working classification of chronic myeloproliferative disorders based on histological, haematological and clinical finclings.J clin Path 39, 237 (1986).
Georgii A: Histopathology of the bone marrow in human chronic leukaemias, in Neth R, Gallo R C, Hofshneider P H, Mannweiler K (eds):Modern Trends in Human Leukemia III, pp. 59–70. Berlin, Springer (1979).
Georgii A, Vykoupil K F, Thiele J: Chronic megakaryocytic granulocytic myelosis — CMGM. A subtype of chronic myeloid leukemia.Virchows Arch path Anat Hist 389, 253 (1980).
Jamshidi K, Swaim W R: Bone marrow biopsy with unaltered architecture: a new biopsy device.J Lab clin Med 77, 335 (1971).
Schaefer H E: Leukopoese und myeloproliferative Erkrankungen, in Remmele W (ed):Pathologie, Vol.I, pp. 356–452. Berlin, Springer (1984).
Pearson E S, Hartley H O:Biometrika Tables for Statisticians I and II. London, Cambridge University Press (1970, 1972).
Spearman C: The proof and measurement of association between two things.Am J Psych 15, 72 (1904a).
Spearman C: General intelligence objectively determined and measured.Am J Psych 15, 201 (1904b).
Morrison D F:Multivariate Statistical Methods. New York, McGraw-Hill (1967).
Fisher R A:Statistical Methods for Research Workers. Eclinburgh, Oliver and Boyd (1972).
Sokal J E: Evaluation of survival data for chronic myelocytic leukemia.Am J Hemat 1, 493 (1976).
Mason J E, Devita V T, Canellos G P: Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.Blood 44, 483 (1974).
Wolf D J, Silver R T, Coleman M: Factors associated with prolonged survival in chronic myeloid leukemia.Cancer 42, 1957 (1978).
Albrecht M: “Gaucher-Zellen” bei chronisch myeloischer Leukämie.Blut 13, 169 (1966).
Smith W C, Kaneshiro M M, Goldstein B D, Parker J W, Lukes R J: Gaucher cells in chronic granulocytic leukemia.Lancet 2, 780 (1968).
Gerdes J, Marathe R L, Bloodworth J M B, Mackinney A A: Gaucher cells in chronic granulocytic leukemia.Archs Path 88, 194 (1969).
Rosner F, Dosik H, Kaiser S S, Lee S L, Morrison A N: Gaucher cells in leukemia.J Am Med Ass 209, 935 (1969).
Kattlove H E, Williams J C, Gaynor E, Spivack M, Bradley R M, Brady R O: Gaucher cells in chronic myelocytic leukemia: an acquired abnormality.Blood 33, 279 (1969).
Lee R E, Ellis L D: The storage cells of chronic myelogenous leukemia.Lab Invest 24, 261 (1971).
Dosik H, Rosner F, Sawitsky A: Acquired lipoidosis: Gaucher-like cells and “blue cells” in chronic granulocytic leukemia.Semin Hemat 9, 309 (1972).
Albrecht M: Zur Problematik der “Gaucher-Zellen” bei chronisch-myeloischer Leukämie.Klin Wschr 47, 778 (1969).
Keyserlingk D, Boll I, Albrecht M: Elektronenmikroskopie und Cytochemie der “Gaucher-Zellen” bei chronischer Myelose.Klin Wschr 50, 510 (1972).
Albrecht M: Ergebnisse von Langzeitbeobachtungen bei Patienten mit chronisch myeloischer Leukämie, in Gross R, Van de Loo (eds):Leukämie, pp. 399–404. Heidelberg, Springer (1972).
Thiele J, Fohlmeister I, Vonneguth B, Zankovich R, Fischer R: The prognostic implication of clinical and histological features in Ph 1 + s-chronic myelocytic leukaemia (CML).Anticancer Res 6, 1401 (1986).
Schmahl M: Pseudogaucherzellen und Megakaryozyten bei der chronischen myeloischen Leukämie. Inauguraldissertation. Köln (1983).
Castro-Malaspina H: Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components, in Berk P, Castro-Malaspina H, Wasserman L (eds):Myelofibrosis and the Biology of Connective Tissue, pp. 427–454. New York, Alan R. Liss (1984).
Burstein S A, Malpass T W, Yee E, Kaclin M, Brigden M, Adamson J W, Harker L A: Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.Br J Haemal 57, 383 (1984).
Frisch B, Bartl R: Histology of myelofibrosis and osteomyelosclerosis, in Lewis S M (ed):Myelo-fibrosis. Pathophysiology and Clinical Management, pp. 51–86. New York, Marcel Dekker (1985).
Author information
Authors and Affiliations
Additional information
Supported in part by a grant from the Moritz Foundation, Cologne, West Germany.
Rights and permissions
About this article
Cite this article
Thiele, J., Thienel, C., Zankovich, R. et al. Prognostic features at diagnosis of chronic myeloid leukaemia with special emphasis on histological parameters. Med. Oncol. & Tumor Pharmacother. 5, 49–60 (1988). https://doi.org/10.1007/BF03003181
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03003181